The patients with Grade I serum albumin having good overall patient's nutritional status. Latest improvement in overall disease outcome. Ninety six percent patients completed their treatment free survival is only been possible by the use of aggressive and are alive and no patient relapsed. The expired patient was protocols in the developed countries. The tolerance of these only one. The patients with Grade II, 33% patients completed aggressive protocols based upon the nutritional status of the their treatment and are alive. The percentage of relapsed is 20% patients. With a prevalence of 50% moderate to sever and 46% patients expired. A marked decrease in overall outcome malnutrition it is very difficult to induct the same level of the observed in patients with Grade III serum albumin level of 2.5 -chemotherapeutic dosages. Reduced induction of the drugs 2.00 mg/dl. No patients completed their treatment and are alive. ultimately Leeds to the poor disease free survival and lower Ninety six percent patients expired during the treatment o f morbidity. This study was conducted to determine the effect of standard acute lymphoblastic leukemia. One patient relapsed. serum albumin level (at admission) on the overall outcome of the The results are worst in patients with serum albumin level below treatment of standard acute lymphoblastic leukemia according to 1.9 mg/dl Grade IV. All patients expired during the due course of the FMB protocols.
the treatment according to the FMB protocols. Data and results Posttest-randomized control group was designed to study the showed that serum albumin has significant factor for overall effects of malnutrition classified based upon anthropometric data MAD (Weight, height for age) and malnutrition classified on the bases of visceral protein (Koskelo et al., 1990; 1991; Yu-Le and Kuribidla, 1994 ) MVP (serum total protein and Serum albumin) levels (Ross Laboratories, 1978; Wahling and Georgieff, 1995) during the stay in the hospital, tolerance of the treatments doses and overall outcome during the course of treatment according to FMB protocols. To get a homogenous group of the patients, all patients were inducted in the study that registered in the Pediatric Hematology and Oncology Department for treatment. All patient who were <02 and above 12 years, previous treated, were excluded from the study. Patients with standard ALL, age below 12 and above 02 years, newly diagnosed untreated, registered with the department for treatment were included in the study. Total number of patients : 70 Patients with (ALBUMIN ) Grade I : 28 outcome of the treatment of standard acute lymphoblastic leukemia of childhood. The serum albumin level below 3.00 mg/dl Leeds to very low prognosis and outcome of the treatment for standard acute lymphoblastic leukemia (Koskelo et al., 1991; Lobato-Mendizabal et al., 1989) . The present study concluded that over all recovery above 80 % is only achievable if the patient's serum albumin level is above 3.00 mg/dl. The determination of nutritional status on the basis of visceral protein markers (Koskelo et al., 1991; Lobato-Mendizabal et al.,1989; Lobato-Mendizabal and Ruiz-Argulles, 1990; MarinLopz, 1991) especially serum albumin level are most significant factor for the prognosis than the nutritional status determination on the basis of the anthropometry (weight, height). As Weir et al., 1998 Suggested that nutritional status at diagnosis, defined o n the basis of the body mass index, in developed countries, has no effect on the prognosis in acute lymphoblastic leukemia and i t should not be considered as a prognostic factor, but in under Lobato-Mendizabal, E. and G. J. Ruiz-Argulles, 1990 . (Leukemia developed countries the results are entirely different. I n developed countries the incident of the malnutrition is very low.
